athletes
Conditions
Interventions
This was a randomized, controlled, double-blind, two-arm clinical study in which participants were randomly allocated into two groups. Experimental group – nine (9) female athletes received a leucine-
Sponsors
Universidade Federal de São Paulo (UNIFESP) - Hospital São Paulo - Hospital Universitário da Universidade Federal de São Paulo
Universidade Anhembi Morumbi
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: women aged between 18 and 49 years old, who practice resistance exercise, at least three times a week, for at least one year for one hour/day.
Exclusion criteria
Exclusion criteria: participants who were unable to complete the testing protocol, those who did not adhere to the program, or were injured during the study. women that don´t have between 18 and 49 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that after treatment, the experimental group will show a reduction in cytokine levels measured in saliva of at least one standard deviation compared to the placebo group | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected a reduction in pain scale scores in the lower extremities, as measured by the Visual Analog Pain Scale (VAS), will be observed in the experimental group in comparison to the control group | — |
Countries
Brazil
Contacts
Public ContactTatyana Dall Agnol
Universidade Federal de São Paulo (UNIFESP) - Hospital São Paulo - Hospital Universitário da Universidade Federal de São Paulo
Outcome results
None listed